2024 winners

Junior Research Grant

Sigrún Thorsteinsdóttir Sigrún Thorsteinsdóttir

Topic: Improving the diagnosis and management of smoldering multiple myeloma using analyses of peripheral blood
University of Iceland
Iceland

Lakshmi Sandhow Lakshmi Sandhow

Topic: Endothelial cell plasticity as a therapeutic target in acute myeloid leukemia
Cochin Institute
France

Helga Simon Molas Helga Simon Molas

Topic: Optimizing combination treatment of targeted agents and T-cell engagers in CLL, a metabolic approach
Amsterdam University Medical Center
The Netherlands

Femke Hormann Femke Hormann

Topic: Towards more effective nucleoside analogue treatment of acute lymphoblastic leukemia
Karolinska Institutet
Sweden

Vaclav Seda Vaclav Seda

Topic: The FoxO1-GAB1 axis regulates the microenvironmental interactions of AML cells
CEITEC Masaryk University
Czechia

Advanced Research Grant

Alba Maiques Diaz Alba Maiques Diaz

Topic: Unravelling the functional role and therapeutic potential of transcription factors in chronic lymphocytic leukemia
Consorci d'Investigacions Biomèdiques August Pi I Sunyer
Spain

Serena Scala Serena Scala

Topic: Studying clonal complexity and functional properties of long-term engrafted human Hematopoietic Stem/Progenitor Cells after gene therapy
Ospedale San Raffaele S.R.L.
Italy

Mathijs Sanders Mathijs Sanders

Topic: Drivers of secondary acute myeloid leukemia: internalizing the external
Erasmus University Medical Center
The Netherlands

Virginia Turati Virginia Turati

Topic: Predictive modelling based on tracking clonal evolution in childhood leukaemia as a tool understand the biology of treatment resistance and guide the design of new therapeutic protocols
Lund University
Sweden

Rachel Thijssen Rachel Thijssen

Topic: Role of monosomy 7 in venetoclax resistance in acute myeloid leukaemia
Amsterdam UMC
The Netherlands

Physician Scientists’ Research Grant

Camille Bigenwald Camille Bigenwald

Topic: MACROCAR: Contribution of lymph node macrophages to CAR T cells resistance
Institut Gustave Roussy
France

Simon Richardson Simon Richardson

Topic: Characterisation and targeting of disordered B lineage progenitor states in CREBBP-mutated B cell acute lymphoblastic leukaemia
University of Cambridge
United Kingdom

Delfim Duarte Delfim Duarte

Topic: Investigating the role of iron in TET2 clonal hematopoiesis
Instituto de Biologia Molecular e Celular
Portugal

Tim Dekker Tim Dekker

Topic: Unleashing the force of the tumor microenvironment through immunomodulatory therapies in follicular lymphoma
Leiden University Medical Center
The Netherlands

Topic-in-Focus Advanced Research Grant

Enrica Federti Enrica Federti

Topic: Understanding the role of macrophages at single cell level in sickle cell related pulmonary hypertension
University of Verona
Italy

Bilateral Collaborative Grant

Simón Méndez-Ferrer Simón Méndez-Ferrer

Topic: The role of cholinergic signaling on immune cell metabolism, acute graft-versus-host disease pathogenesis and graft-versus-tumour effect
University of Cambridge
United Kingdom

Petya Apostolova Petya Apostolova

Topic: The role of cholinergic signaling on immune cell metabolism, acute graft-versus-host disease pathogenesis and graft-versus-tumour effect
Basel University Hospital
Switzerland

Björn Chapuy Björn Chapuy

Topic: Decoding the Role of the Noncoding Genome in Diffuse Large B-Cell Lymphoma (noncoDLBCL)
Charité, University Medicine Berlin
Germany

Biola Javierre Biola Javierre

Topic: Decoding the Role of the Noncoding Genome in Diffuse Large B-Cell Lymphoma (noncoDLBCL)
Josep Carreras Leukaemia Research Institute
Spain

Immacolata Andolfo Immacolata Andolfo

Topic: Dissecting the role of PIEZO1 in liver sinusoidal endothelial cells to identify new druggable targets for iron overload
Università degli Studi di Napoli Federico II
Italy

Martina Muckenthaler Martina Muckenthaler

Topic: Dissecting the role of PIEZO1 in liver sinusoidal endothelial cells to identify new druggable targets for iron overload
University of Heidelberg, Heidelberg
Germany

Research Mobility Grant

Luigia Valsecchi Luigia Valsecchi

Topic: Identification of MSI2 direct targets in KMT2A-rearranged infant Acute Lymphoblastic Leukemia through HyperTRIBE system
Fondazione IRCCS, San Gerardo dei Tintori
Italy

Cassandre Petit Cassandre Petit

Topic: Immune responses after CALR targeted therapies
Institut Paoli Calmette - Aix Marseille University
France

Maria Magallon Mosella Maria Magallon Mosella

Topic: Studying the Role of Bone Marrow Niche in GATA2 Deficiency (BMN-G2D)
Fundació Institut d’Investigació Biomèdica de Bellvitge – IDIBEL
Spain

David Fernando Moreno Fajardo David Fernando Moreno Fajardo

Topic: Single cell whole genome interrogation of relapsed/refractory multiple myeloma patients after anti-BCMA CAR T cell ARI0002h therapy
Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS)
Spain

Markéta Racková Markéta Racková

Topic: Evaluating the application of cfDNA analysis in studying the pathogenesis of pediatric PTLDs
Charles University
Czechia

Giulia Vari Giulia Vari

Topic: High-throughput miRNA functional screening to identify regulators predictive of response to novel treatment in relapsed/refractory diffuse large B-cell lymphoma patients
IRCCS Regina Elena National Cancer Institute and “Sapienza” University
Italy

Eliška Jandová Eliška Jandová

Topic: Epigenetic regulation of CD123
Charles University
Czechia

Veronika Zimolová Veronika Zimolová

Topic: Investigating the role of CMTR1 in erythrocytosis using iPSCs
Institute of Molecular Genetics of the Czech Academy of Sciences
Czechia

Rathick Sivalingam Rathick Sivalingam

Topic: Characterization of RNA-binding proteins in acute myeloid leukemia driven by the KMT2A-MLLT3 fusion oncogene
University of Basel
Switzerland

Ismael de la Iglesia San Sebastian Ismael de la Iglesia San Sebastian

Topic: Unraveling Mechanisms of Response in CAR T-Cell Therapy in T Cell Lymphomas: A Single-Cell RNAseq Approach
Hospital General Universitario Gregorio Marañón
Spain

Angelica Varesi Angelica Varesi

Topic: Leveraging mechanical forces for gene therapies
University Health Network, University of Toronto
Canada

Sophie Hordijk Sophie Hordijk

Topic: Optical imaging of Weibel-Palade body exocytosis in patient-derived endothelial cells to unravel the impact of pathogenic MADD mutations on Von Willebrand factor secretion
Erasmus Medical Center
The Netherlands

Natalie Wickli Natalie Wickli

Topic: The role of CXCR4 in synchronised erythropoiesis of human pluripotent stem cells
Institute of Cell Biology and Immunology Thurgau
Switzerland

Innovation Grant

Paolo Gallipoli Paolo Gallipoli

Topic: Optimising therapies targeting fatty acid desaturation in AML
Barts Cancer Institute, Queen Mary University of London
United Kingdom

Jean-Emmanuel Sarry Jean-Emmanuel Sarry

Topic: Optimising therapies targeting fatty acid desaturation in AML
Cancer Research Institute of Montpellier
France

Vilma Dembitz Vilma Dembitz

Topic: Optimising therapies targeting fatty acid desaturation in AML
University of Zagreb
Croatia

Shahram Kordasti Shahram Kordasti

Topic: The International Integrative Innovative Immunology for MDS (i4MDS)
King's College London
United Kingdom

Uwe Platzbecker Uwe Platzbecker

Topic: The International Integrative Innovative Immunology for MDS (i4MDS)
Leipzig University
Germany

Wolfgang Kern Wolfgang Kern

Topic: The International Integrative Innovative Immunology for MDS (i4MDS)
MLL Labs
Germany

António Almeida António Almeida

Topic: The International Integrative Innovative Immunology for MDS (i4MDS)
Hospital de Luz Lisboa
Portugal

Oscar Brück Oscar Brück

Topic: Large-Scale Screening of Myeloid Neoplastic Precursor States using Blood Cell Morphology (MorphoSCREEN)
Helsinki University Hospital
Finland

Jette Lengefeld Jette Lengefeld

Topic: Large-Scale Screening of Myeloid Neoplastic Precursor States using Blood Cell Morphology (MorphoSCREEN)
Karolinska Insitutet
Sweden

Brankica Simac Brankica Simac

Topic: Large-Scale Screening of Myeloid Neoplastic Precursor States using Blood Cell Morphology (MorphoSCREEN)
Dubrava University Hospital
Croatia

Torsten Haferlach Torsten Haferlach

Topic: Large-Scale Screening of Myeloid Neoplastic Precursor States using Blood Cell Morphology (MorphoSCREEN)
Munich Leukemia Laboratory
Germany